H, A., Y, N., KH, C., AD, B., M, M., W, M., . . . M, A. (2025). Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia. Blood cancer journal, 15(1), 76. https://doi.org/10.1038/s41408-025-01266-0
Chicago Style (17th ed.) CitationH, Akiyama, et al. "Dual Targeting of EZH2 and EZH1 Drives Exit of Leukemia Stem Cells from Quiescence and Potentiates Chemotherapy in Acute Myeloid Leukemia." Blood Cancer Journal 15, no. 1 (2025): 76. https://doi.org/10.1038/s41408-025-01266-0.
MLA (9th ed.) CitationH, Akiyama, et al. "Dual Targeting of EZH2 and EZH1 Drives Exit of Leukemia Stem Cells from Quiescence and Potentiates Chemotherapy in Acute Myeloid Leukemia." Blood Cancer Journal, vol. 15, no. 1, 2025, p. 76, https://doi.org/10.1038/s41408-025-01266-0.